The role of cerebral ischemia in Alzheimer's disease

R N Kalaria1

  • 1Wolfson Research Centre, Institute for Health of the Elderly, Newcastle General Hospital, Westgate Road, NE4 6BE, Newcastle upon Tyne, United Kingdom. r.n.kalaria@ncl.ac.uk

Neurobiology of Aging
|June 27, 2000
PubMed

Insights

Vascular risk factors, like those causing stroke, significantly increase Alzheimer's disease (AD) risk. Cerebral ischemia may promote AD changes, highlighting the importance of managing vascular disease for dementia prevention.

Area of Science:

  • Neurology
  • Gerontology
  • Vascular Medicine

Background:

  • Alzheimer's disease (AD) and stroke incidence rise with age.
  • Vascular risk factors are increasingly linked to AD development.
  • Cerebrovascular pathology is prevalent in AD cases.

Purpose of the Study:

  • To explore the relationship between stroke and Alzheimer's disease.
  • To investigate if cerebral ischemia contributes to Alzheimer's type changes.
  • To emphasize the role of vascular factors in dementia.

Main Methods:

  • Review of autopsy series and longitudinal clinical studies.
  • Examination of vascular factors and pathophysiology in stroke and AD.
  • Analysis of co-existence and interaction between stroke and AD.

Main Results:

  • A significant overlap exists between cerebrovascular pathology and AD.
  • Strokes exacerbate cognitive decline in Alzheimer's patients.
  • Cerebral ischemia/oligemia is proposed as a promoter of AD changes.

Conclusions:

  • Vascular disease management is crucial for preventing or treating Alzheimer's disease and mixed dementia.
  • Cerebral ischemia may be a causal factor in Alzheimer's disease.
  • Understanding the interplay between vascular health and cognitive decline is essential.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...